Tehran University of Medical Sciences

Science Communicator Platform

Share By
Determining the Safety and Effectiveness of Endor Oral Combination Drug in the Treatment of Patients With Covid-19: A Randomized Controlled Trial Publisher



Mohraz M ; Kazerooni SE ; Seifi A ; Manshadi SAD ; Alinaghi SAS ; Golestan FS ; Nikkhoo S ; Abdollahi A ; Jafari S ; Hajrahimi M
Authors

Source: Acta Medica Iranica Published:2025


Abstract

The novel coronavirus caused by SARS-CoV-2 is still a public health concern as it can have dire consequences. Anti-inflammatory drugs are promising. Therefore, this study aimed to determine the safety and effectiveness of the ENDOR oral combination drug in the treatment of patients with COVID-19. This double-blinded, randomized controlled trial was conducted at the Imam Khomeini Hospital complex in Tehran, Iran. All COVID-19 patients who were admitted to the Imam Khomeini hospital complex from April 2022 to April 2023 and who were 18-75-Year-Old signed the consent form to participate in this study, were not pregnant, and did not need mechanical ventilation at admission. In this study of 200 patients (50% in the Endor group and 50% in the placebo group), 56.8% were male, and the mean age was 65.02±14.94. There were no statistically significant differences observed between the Endor and control groups across time for temperature (P=.075), WBC (P=.095), CRP (P=.108), sodium (P=.323), or calcium (P=.352). The slope of the decrease in ESR and the body temperature, as well as the slope of the increase in oxygen saturation in the Endor group, was higher than in the control group. Statistically significant differences between the Endor and control groups over time for respiratory rate (P=.003), oxygen saturation (P<.001), and potassium (P=.031) were observed. The decreasing slope of the respiratory rate in the Endor group was significantly higher than in the control group. ENDOR with anti-inflammatory features helps COVID-19 hospitalized patients recover faster by improving oxygen saturation, lowering fever, and decreasing respiratory rate. © 2025 Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. A Randomized Controlled Clinical Trial on Efficacy and Safety of Anakinra in Patients With Severe Covid-19, Immunity# Inflammation and Disease (2022)
2. Corticosteroids on the Management of Coronavirus Disease 2019 (Covid-19): A Systemic Review and Meta-Analysis, Iranian Journal of Public Health (2020)
3. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
Experts (# of related papers)
View all Related Experts
Behnam Behnoush (1)
Ahmad Reza Jamshidi (1)
Other Related Docs
4. Methylprednisolone Pulse Therapy Compared With Intravenous Dexamethasone for Severe Covid-19 Patients: A Randomized Clinical Trial, Virology Journal (2025)
5. Safety and Efficacy of Incentive Spirometer in Covid-19 Pneumonia; a Randomized Clinical Trial, Archives of Academic Emergency Medicine (2024)
6. Long-Term Major Adverse Cardiovascular Events in Patients With Moderate and Severe Covid-19: A Focus on Early Statin Use and Previous Cvd, Journal of Tehran University Heart Center (2023)
7. Tocilizumab Failed to Reduce Mortality in Severe Covid-19 Patients: Results From a Randomized Controlled Clinical Trial, Iranian Journal of Allergy# Asthma and Immunology (2024)
8. Effectiveness of Fortified Garlic Extract Oral Capsules As Adjuvant Therapy in Hospitalized Patients With Coronavirus Disease 2019: A Triple-Blind Randomized Controlled Clinical Trial, Current Therapeutic Research - Clinical and Experimental (2023)
9. Comparing Therapeutic Versus Prophylactic Enoxaparin Therapy in Severe Covid-19 Patients: A Randomized Clinical Trial, Medical Journal of the Islamic Republic of Iran (2023)
10. Efficacy and Safety of Arbidol in Treatment of Patients With Covid-19 Infection: A Randomized Clinical Trial, Journal of Iranian Medical Council (2022)
11. The Association Between Enteral Nutrition With Survival of Critical Patients With Covid-19, Immunity# Inflammation and Disease (2024)
12. Evaluation of Clinical Outcomes in Covid-19 Patients Receiving Remdesivir in Outpatient Setting, Iranian Journal of Pharmaceutical Sciences (2024)